ATYR vs PH · rev $190.0K vs P/E 28, rev $19.85B
aTyr Pharma, Inc. (ATYR) versus Parker-Hannifin Corporation (PH) — a side-by-side from cached financials, not a winner call.
aTyr Pharma, Inc. (ATYR) is a biotechnology company listed on US.
Parker-Hannifin Corporation (PH) is a specialty industrial machinery company listed on US.
Latest reported ATYR revenue for 2025-12-31 was $190.0K. Net income was -$74.1M. Revenue was down 19.1% from 2024-12-31 to 2025-12-31. ATYR currently screens at market cap $471.7M.
Latest reported PH revenue for 2025-06-30 was $19.85B. Net income was $3.53B. PH currently screens at market cap $91.89B and trailing P/E 27.7.
ATYR currently screens at market cap $471.7M. PH currently screens at market cap $91.89B and trailing P/E 27.7.
Not investment advice. Open the ATYR and PH stock pages for the full models.
Not investment advice.